A groundbreaking sensor, inspired by nature's own protective mechanisms, has emerged from the collaboration between La Trobe University and CSIRO. This sensor, designed to mimic cell surfaces, has the potential to revolutionize real-time health monitoring and personalized medicine. The key innovation lies in its ability to overcome the challenges posed by blood's inherent difficulty in being measured. By employing a natural protective coating called lubricin and fast-responding DNA-based receptors, the sensor can detect minute molecular changes in blood without the interference caused by blood's tendency to clog sensors. This breakthrough is particularly significant as it addresses long-standing issues in sensitivity, response speed, and surface fouling, making it the first practical, real-time SERS sensor capable of operating within a fluid like blood.
The sensor's performance is remarkable. It can detect the antibiotic Vancomycin in unprocessed blood samples without any loss in sensitivity over an extended period of 10 hours. This level of sensitivity, 100 million times more than previous methods, opens up new possibilities for real-time molecular monitoring. Associate Professor Wren Greene emphasizes the sensor's expanded detection range, enabling the measurement of hormones, toxins, and other biomarkers at low concentrations, which is crucial for early disease detection and treatment monitoring.
The research team's achievement is a significant step towards the realization of real-time health systems that can automatically adjust drug delivery and provide early warnings to clinicians. The sensor's potential to detect a wide range of molecules and its ability to operate continuously make it a powerful tool for personalized medicine. Looking ahead, the team aims to prototype an inexpensive, mass-produced 'test strip', similar to a blood-glucose test, which could make advanced health monitoring more accessible to the general public.
This breakthrough has been published in the journal ACS Sensors, showcasing the collaboration between La Trobe University, CSIRO, and industry partners. The research was supported by the ARC Research Hub for Molecular Biosensors at Point-of-Use (MOBIUS), highlighting the importance of interdisciplinary efforts in advancing scientific discoveries. As the sensor technology continues to evolve, it holds the promise of transforming healthcare by providing real-time, personalized monitoring and treatment adjustments.
